help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harrod, K. S.
Right arrow Articles by Reed, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harrod, K. S.
Right arrow Articles by Reed, M. D.
American Journal of Respiratory Cell and Molecular Biology. Vol. 28, pp. 451-463, 2003
© 2003 American Thoracic Society
DOI: 10.1165/rcmb.2002-0100OC

Increased Susceptibility to RSV Infection by Exposure to Inhaled Diesel Engine Emissions

Kevin S. Harrod, Richard J. Jaramillo, Cynthia L. Rosenberger, Shan-Ze Wang, Jennifer A. Berger, Jacob D. McDonald and Matthew D. Reed

Asthma and Pulmonary Immunology Program, and Experimental Toxicology Program, Lovelace Respiratory Research Institute, Albuquerque, New Mexico

Address correspondence to: Kevin S. Harrod, Ph.D., Asthma and Pulmonary Immunology, Lovelace Respiratory Research Institute, 2425 Ridgecrest Dr. SE, Albuquerque, NM 87108. E-mail: kharrod{at}lrri.org


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Although epidemiologic data strongly suggest a role for inhaled environmental pollutants in modulating the susceptibility to respiratory infection in humans, the underlying cellular and molecular mechanisms have not been well studied in experimental systems. The current study assessed the impact of inhaled diesel engine emissions (DEE) on the host response in vivo to a common pediatric respiratory pathogen, respiratory syncytial virus (RSV). Using a relatively resistant mouse model of RSV infection, prior exposure to either 30 µg/m3 particulate matter (PM) or 1,000 µg/m3 PM of inhaled DEE (6 h/d for seven consecutive days) increased lung inflammation to RSV infection as compared with air-exposed RSV-infected C57Bl/6 mice. Inflammatory cells in bronchoalveolar lavage fluid were increased in a dose-dependent manner with regard to the level of DEE exposure, concomitant with increased levels of inflammatory mediators. Lung histology analysis indicated pronounced peribronchial and peribronchiolar inflammation concordant with the level of DEE exposure during infection. Mucous cell metaplasia was markedly increased in the airway epithelium of DEE-exposed mice following RSV infection. Interestingly, both airway and alveolar host defense and immunomodulatory proteins were attenuated during RSV infection by prior DEE exposure. DEE-induced changes in inflammatory and lung epithelial responses to infection were associated with increased RSV gene expression in the lungs following DEE exposure. These findings are consistent with the concept that DEE exposure modulates the lung host defense to respiratory viral infections and may alter the susceptibility to respiratory infections leading to increased lung disease.

Abbreviations: bronchoalveolar lavage fluid, BALF • Clara cell secretory protein, CCSP • diesel engine emissions, DEE • enzyme-linked immunosorbent assay, ELISA • interferon-{gamma}, IFN-{gamma} • mucous cell metaplasia, MCM • plaque-forming units, pfu • particulate matter, PM • respiratory syncytial virus, RSV • tumor necrosis factor-{alpha}, TNF-{alpha}


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Respiratory infections constitute the greatest health impact to children worldwide. Respiratory viral infections in children are the primary cause of lung disease leading to diminished lung function and capacity (1). Viral infections early in life have been linked to the increased incidence of lung disease, particularly asthma, throughout childhood (2). Respiratory syncytial virus (RSV) is the most common cause of respiratory infection in young children, infecting virtually every child by the age of two (3). RSV infections of the lower respiratory tract often lead to hospitalization in this age group and can cause severe or chronic bronchitis and wheezing. Importantly, infection in young children does not induce strong viral immunity against secondary and subsequent infections, which have hampered traditional vaccine prophylaxis. The mechanisms of lung pathogenesis to RSV have not been fully elucidated, but lung-specific host defense appears to be important in modulating lung pathogenesis during infection (4).

The impact of environmental pollutants and poor air quality on respiratory infections has been suggested primarily based upon epidemiology studies examining clinical data during episodes of air pollution (5). Hospitalizations, physician visits, school absenteeism, and asthmatic episodes have been correlated in children during times of elevated particulate matter (PM) or ozone in urban settings (6, 7). Engine emissions continue to have a tremendous impact on air quality in the United States. Yet, the biological health effects of exposure to diesel engine emissions (DEE) have not been fully assessed, particularly to acute respiratory disease. In experimental models, PM from DEE exacerbates the host response to bacterial infections of the lung, likely occurring through mechanisms of altered bacterial clearance (8, 9). However, many of these studies have only examined filter-captured components of DEE (1012) and do not examine others, such as gaseous-phase emission components.

In the current study, whole mixtures of inhaled DEE were used to assess the effect of DEE exposure on the host response to subsequent RSV infection in vivo. Multiple levels of DEE exposure were assessed in a relatively RSV-resistant mouse strain at the time of peak viral titers following infection. The DEE exposure concentrations resemble levels ranging from high ambient to high levels occupational settings, thus providing information regarding possible health effects of DEE in human disease. Following exposure to DEE, lung inflammation and pathogenesis to RSV infection were increased concordant with decreased RSV clearance in lung tissues. These studies provide the first evidence of increased lung disease to RSV by prior exposure to DEE in vivo, and suggest a role for ambient DEE in the increased susceptibility to respiratory viral infection.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Reagents
All reagents were obtained from Sigma Chemicals (St. Louis, MO) unless otherwise noted. For protein analysis studies, surfactant protein antibodies were purchased from Chemicon (Temecula, CA). PCR primer oligonucleotides were obtained from Sigma Genosys (The Woodlands, TX). All antibody and detection reagents for immunohistochemistry were purchased from Vector Laboratory (Burlingame, CA). Secondary antibodies for Western blot analysis were purchased from Calbiochem (San Diego, CA), and chemiluminescence reagents were obtained from Amersham Pharmacia Biotech (Piscataway, NJ).

DEE Generation and Exposure
Exhaust generation, dilution, and environmental conditions have been described in detail in the protocol for the National Environmental Respiratory Center (NERC) Core Study I: Contemporary Diesel Emissions on the NERC website (www.nercenter.org). Briefly, diesel exhaust was generated by one of two Cummins 2000 model 5.9-liter turbo diesel engines fueled by Number 2 Diesel Certification Fuel and operated on a repeated (20-min) version of the EPA heavy-duty test cycle. Exposures were conducted by whole body inhalation (Hazelton H2000 chambers; Lab Products, Maywood, NJ), 6 h/d for seven consecutive days. Temperature, humidity, and PM concentrations were monitored continuously and maintained as described (www.nercenter.org). DEE concentrations for each chamber were achieved by dilution with HEPA-filtered ambient air to a daily mean average of 30 (designated hereafter as "low-level") and 1,000 ("high-level") µg/m3 PM, respectively. Control exposures were conducted with diluted HEPA-filtered ambient air.

Exposure atmospheres were monitored daily for the concentration of PM and Nitrogen Oxides (NOx), which is the sum of nitrogen oxide (NO) and nitrogen dioxide (NO2). These measurements were used both to define the exposure concentration and to provide information for adjusting system dilutions to achieve the target exposure concentrations. PM concentration was monitored by deposition on 47-mm Pallflex (Pall-Gelman, Ann Arbor, MI) filters. Pre- and post-filter weights were measured using a Mettler MT5 balance (Mettler, Columbus, OH). A static discharger was used before weighing to avoid any interference from electrical charge on the filters. Filter samples were collected three times (every 2 h) from the high-level and twice (every 3 h) from the low-level exposures. One filter sample per day was collected from the control chamber. Total NOx were measured using a chemiluminescent analyzer (API Model 200A NOx Analyzer; Teledyne Instr., San Diego, CA). Carbon monoxide was determined using a Photoacoustic Gas Analyzer (Innova 1312; California Analytical Instruments, Irvine, CA). Both NOx and CO analyzers were calibrated before each study using National Institute of Standards and Technology traceable standards. SO2 was collected utilizing potassium carbonate impregnated filters and analyzed by ion chromatography (500DX; Dionex, Sunnyvale, CA). Particle size was measured using a 10-stage micro-orifice–uniform deposit impactor (MOUDI; MSP Corp. St. Paul, MN). The MOUDI was operated at a flow rate of 30 liters/min, providing particle size resolution from 0.05–10 µm in aerodynamic diameter.

RSV Culture and Titration
RSV (A2 strain, a generous gift from Dr. Barney Graham, National Institutes of Health) was propagated in Hep-2 cell cultures as described previously (13). Purified RSV was titrated in triplicate for each culture dilution using standard plaque assay procedures. Plaque formation was counted manually by visualization following hematoxylin staining of cell monolayers.

Animal Husbandry and Intratracheal Administration of RSV
C57Bl/6 mice (Jackson Laboratories, Bar Harbor, ME) were purchased and housed under pathogen-free housing conditions according to AAALAC-approved guidelines and protocols. Routine serologic analysis of mouse pathogens was negative throughout the study period. Mice were housed in exposure chambers for the duration of the exposure period with water provided ad libitum and food provided during nonexposure hours. RSV (100 µl) was instilled under light anesthesia by dilution of RSV stock cultures to 107 plaque forming units (pfu)/ml with sterile, endotoxin-free phosphate-buffered saline (PBS), into the lung to achieve a final delivery of 106 pfu of virus. Mice were infected immediately following the final 6-h exposure period. Mice resumed normal feeding and grooming activities within 15 min of virus instillation. Following infection, mice were housed under pathogen-free conditions in a designated Biosafety Level 2 animal facility for the duration of the study.

Reverse Transcriptase–Polymerase Chain Reaction Analysis of Viral Gene Expression
Reverse transcriptase–polymerase chain reaction (RT-PCR) analysis was designed to detect nascent viral mRNA transcripts, but not detect genomic or progeny RSV RNA, as a measure of viral transcriptional activity. Total lung RNA was isolated by Tri-reagent (Molecular Research Center, Cincinnati, OH) according to the manufacturer's recommendations. Virus-specific mRNA transcripts for RSV genes F and G (designated RSV-F and RSV-G, respectively) were converted to cDNA by the reverse transcription reaction using the following virus-specific primer sequences: RSV-F, 5'-CAACTCCATTGTTATTTGCC-3'; RSV-G, 5'-GACCAACGCACCGCTAAGA-3'. RSV-specific sequences were amplified by PCR using the following primer sets: RSV-F Upper Primer, 5'-CCAGCAAAGTGTTAGACCTCAAAA-3'; RSV-F Lower Primer, 5'-AATCGCACCCGTTAGAAAATG-3'; RSV-G Upper Primer, 5'-CTCGGCAAACCACAAAGTCA-3'; RSV-G Lower Primer, 5'-GCAGATAGCCCAGCAGGTT-3'. Primer sequences were identified using Lasergene software (DNASTAR, Madison, WI). The RSV-specific sequences were amplified for 30 cycles, and RT-PCR amplification products were visualized by ethidium bromide–stained gel electrophoresis under UV light illumination. Gel images were captured and densitometric anaylsis performed using the Gel-Doc documentation system and Quantity One software (BioRad, Hercules, CA).

Inflammatory Cells in Bronchoalveolar Lavage Fluid
Bronchoalveolar lavage fluid (BALF) was collected from the lungs of killed mice by three successive instillations of 1 ml of sterile PBS, and the samples pooled. After the cellular fraction was collected by centrifugation (100 x g), cells were counted by hemacytometer following trypan blue exclusion staining for cell viability. Nonviable, tyrpan blue–stained cells were excluded from analysis. In all studies, nonviable cells comprised less than 1% of the total cell population recovered in BALF. Differential staining of cells collected by cytospin centrifugation was used a Giemsa-Wright modified stain, and cell populations were determined by counting of three to five microscopic fields of two slides from each BALF sample.

Lung Histology and Immunohistochemical Analysis
Right lung lobes were inflation-fixed with 4% paraformaldehyde in PBS and embedded in paraffin blocks as described previously (14). Lung sections (5 µm) were taken starting 100 µm from the designated reference point, and lung sections collected at 100-µm intervals. Lung histology was assessed on hematoxylin and eosin–stained lung sections, and scored (0-4 scale) blindly under light microscopy as described in detail (15). For histologic scoring, two lung sections at equivalent distances from the reference point were scored for each of 8–10 animals per exposure and/or infection condition, for a total of 32 lung sections scored per experimental condition. Typically, transverse lung sections 100 µm and 500 µm from the caudal aspect of the junction of the mainstem bronchus with lung were analyzed. Inflammatory cell populations were determined in histologic lung sections by random selection of 3–5 microscopic fields under light microscopy and 100 total inflammatory cells counted. Criteria for cell identification used cell size, staining pattern, and nuclear appearance to distinguish macrophages, lymphocytes, or neutrophils (polymorphonuclear cells).

For mucous cell metaplasia (MCM) studies, lung sections were stained with Periodic Acid Schiff and Alcian Blue as described previously (16). For quantification of MCM, first- or second-generation intrapulmonary bronchi were analyzed for the volume of mucosubstances by Scion Image software (NIH, Bethesda, MD), and mucosubstance calculations normalized to mm2 of basal lamina as described previously (17).

For immunohistochemical studies, lung sections were prepared as described previously (18, 19). Briefly, lung sections (5 µm) were taken at equivalent distances from the histologic reference point and were stained overnight with primary rabbit antibodies against selected proteins. Slides were rinsed in physiologic buffer and incubated with secondary goat anti-rabbit antibodies conjugated to biotin. A streptavidin-conjugated peroxidase detection system (Vector Laboratory) was used to visualize antibody-binding complexes following incubation with diaminobenzidine. Multiple sections from each tissue block were analyzed under light microscopy. Clara cell secretory protein (CCSP) staining was quantified by adaptation of MCM staining procedure as described previously (17).

Inflammatory Cytokine Analysis
Tumor necrosis factor (TNF)-{alpha} and interferon (IFN)-{gamma} levels were measured by enzyme-linked immunosorbent assay (ELISA) (Biosource, Camarillo, CA). Protein concentrations from lung homogenates were determined by protein assay (Bio-Rad), and equivalent protein concentrations were analyzed in triplicate for cytokine levels.

Western Blot Analysis
Five to 10 µg of protein from lung homogenates were separated by acrylamide gel electrophoresis under reducing conditions and electroblotted to nitrocellulose membranes (Bio-Rad). Protein levels were visualized by autoradiography following chemiluminescence. Densitometric analysis of CCSP immunoblots was performed using a Fluor-S Max Multiimager and Quantity One quantitation software (Bio-Rad).

Statistical Analysis
An institutional biostatistician verified all statistical approaches. For data sets of normal distribution, either a one-way or two-way ANOVA was performed, with post hoc tests for determination of statistical significance at P <= 0.05. For non-normal distributed data sets, statistical analysis using nonparametric tests or logarithmic transformation of data to normal distribution sets and subsequent ANOVA was performed.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
DEE Exposure Characterization
Table 1 shows a summary of exposure concentrations of PM, NOx, CO, and SO2 for DEE exposures as described herein. Diesel PM is the total PM minus the PM measured in the control chamber. Although air flowing through the control chamber is particle free, small amounts of PM that arise from suspension of rodent dander are measured in the control chamber. Assuming that the dander contribution to PM is the same in each exposure chamber, the control PM value is subtracted from the exposure chamber PM to yield "Diesel PM." The low-level DEE exposure was actually 38.8 µg/m3, whereas the high-level DEE exposure was 1,027.3 µg/m3. The gaseous co-pollutants shown in Table 1 ranged from 2.0–43.3 ppm for NOx (~ 90% = NO), 0.94–29.0 ppm CO, and 8.3–364.9 ppb SO2. The particle size measurements (not shown in Table 1) showed aerodynamic mass median diameters between 0.1 and 0.2 µm at both the low-level and high-level target exposure levels.


View this table:
[in this window]
[in a new window]
 
TABLE 1 Summary of exposure concentrations of particle mass, nitrogen oxides, carbon monoxide, and sulphur dioxide

 
Increased Viral Gene Expression in the Lungs by Prior Exposure to Inhaled DEE
C57Bl/6 mice (8-10 wk of age) were exposed to DEE by aerosol inhalation for 6 h/d for seven consecutive days, whereby RSV infection was subsequently introduced by intratracheal administration of 106 pfu under light anesthesia. To assess the impact of DEE exposure on lung viral gene expression, total RNA was isolated from the lungs of mice 4 d after RSV infection. RT-PCR analysis of the viral-specific genes RSV-F and RSV-G was performed using total RNA and visualized by ethidium bromide–stained gel electrophoresis. RT-PCR analysis of endogenous ß-actin mRNA steady-state levels was used as loading and assay controls. At 4 d after infection, RSV-F gene expression was not readily apparent in the lungs of air-exposed, infected animals, whereas RSV-G gene expression was detectable, albeit at very low levels (Figure 1A). In comparison, RSV-F and RSV-G gene expression was readily discernible and markedly elevated in the lungs of infected animals following exposure to either low- or high-level DEE. The increase in RSV gene expression following DEE exposure was not discernible between animals exposed to either low- or high-level DEE. ß-Actin mRNA steady-state levels were not changed in the lungs of DEE-exposed animals as compared with air-treated control animals. Densitometric analysis of RSV-F and RSV-G mRNA levels is shown in Table 2, indicating a 10- to 20-fold induction in the level of RSV-G mRNA in the lungs of DEE-exposed mice as compared with air-exposed controls.




View larger version (91K):
[in this window]
[in a new window]
 
Figure 1. (A) RSV gene expression is increased by prior exposure to inhaled DEE. RSV-F and RSV-G steady-state, positive-strand RNA levels were assessed by RT-PCR at 4 d after infection in mice that had been previously exposed for 7 d to either air, low-level or high-level DEE as described in MATERIALS AND METHODS. RSV-F and RSV-G amplified cDNA was visualized by ethidium bromide–stained gel electrophoresis. RSV-F and RSV-G gene expression was increased by prior exposure to either low- or high-level DEE. ß-Actin levels were unchanged between sample sets; n = 6–8 animals per group analyzed from two independent studies. Densitometry of RSV-F and RSV-G mRNA levels by RT-PCR analysis is represented in Table 2. (B) Inflammatory cell counts in BALF of RSV-infected mice following inhaled DEE exposure. BALF cells were collected 4 d following infection and counted by hemacytometer following trypan blue exclusion staining. Cell counts in BALF were statistically increased by prior exposure to high-level DEE in either sham- or RSV-infected lungs compared with HEPA-filtered air exposure of sham- or RSV-infected lungs. Data represent mean ± SE of n = 6–8 animals per group analyzed from two independent experiments. *Denotes statistical significance of P <= 0.05 as compared with air-exposed, sham-infected data. **Denotes statistical significance of P <= 0.05 as compared with air-exposed, RSV-infected data.

 

View this table:
[in this window]
[in a new window]
 
TABLE 2 Analysis of RSV gene expression 4 d after infection following prior exposure to inhaled diesel engine emission

 
DEE Exacerbated Lung Inflammation to RSV Infection
Morphologic staining and hemacytometer counting of inflammatory cells were determined in BALF from the lungs of air- or DEE-exposed, RSV-infected, and uninfected mice. Cell numbers in BALF from the lungs of air-treated, vehicle-instilled animals were not changed from naive animals, consisting of normally resident alveolar macrophages (data of cell-type specific staining not shown). Following RSV infection, cell numbers in the BALF from air-treated animals were not elevated (Figure 1B). Exposure to low-level DEE did not induce a statistically significant increase in cell numbers as compared with those of air-treated, infected animals. However, exposure to high-level DEE caused an increase in cell numbers in BALF following RSV infection, as compared with that of air-treated, RSV-infected mice. Increased cell numbers were also detected in BALF from uninfected animals exposed to high-level DEE, as compared with uninfected animals exposed to air. In all groups, alveolar macrophages were the predominant cell type (>95%), and no substantial changes in infiltrating cell populations by exposure to DEE were noted (Table 3). Statistical power analysis of low-level DEE samples indicates that larger sample sizes (n >= 20) may be required to delineate a statistical increase in inflammatory cells in BALF from uninfected mice exposed to low-level DEE exposure alone, as compared with that of uninfected, air-treated mice.


View this table:
[in this window]
[in a new window]
 
TABLE 3 Comparison of inflammatory cell populations from BALF and lung histologic studies

 
Lung Inflammation and Airway Epithelial Remodeling to RSV Infection Are Augmented by DEE
To assess histologic changes in the lungs following DEE exposure and RSV infection, lung sections (5 µm) were stained by standard hematoxylin-eosin procedures and scored blindly under light microscopy. Lung sections from air- or DEE-exposed, uninfected groups did not exhibit any observable change when examined (Figure 2A). At 4 d following RSV infection, lung sections of air-treated animals did not show discernible changes in either lung infiltrates or the lung epithelium. Increased inflammatory cell infiltration was noted in peribronchial regions in the lungs of RSV-infected animals following low-level DEE exposure as compared with that of air-exposed, RSV-infected animals. Areas of consolidated inflammatory cell infiltrates were distinct. Furthermore, airway epithelial structure was altered, consisting of loss of the normal cuboidal appearance of nonciliated bronchiolar epithelial (Clara) cells. Occasional regions exhibited columnar epithelial appearance and increased thickening of the myofibril layer in the basal compartments of the airway. These changes were further apparent in the lungs of RSV-infected animals exposed to high-level DEE. Lung inflammation, particularly surrounding bronchi and bronchioles, was strikingly apparent in lung sections of RSV-infected, high-level DEE animals. Morphologic changes in airway epithelial cells were readily observable, with the increased appearance of pseudostratified, columnar epithelial cell morphology and apparent airway epithelial cell sloughing. Both lung inflammation and airway epithelial morphology were further changed in the lungs of high-level DEE-exposed mice as compared low-level DEE exposure following RSV infection, indicating a dose-related increase in lung histopathology to RSV infection by prior exposure to DEE. Scoring of the histologic changes as assessed by light microscopy is presented in Figure 2B. Comparison of the inflammatory cell populations in the lungs of DEE-exposed, RSV-infected mice as determined by BALF studies or histologic analysis is shown in Table 3. In short, both analyses indicate that the macrophages and monocytes were the predominant inflammatory cell type in the lungs of DEE-exposed mice at 4 d following RSV infection.



View larger version (46K):
[in this window]
[in a new window]
 
Figure 2. Lung histopathology and inflammation to RSV at 4 d after infection are increased by prior exposure to inhaled DEE. Hematoxylin and eosin–stained lung sections (5 µm) were assessed by light microscopy, and lung histopathology and inflammation were blindly scored using a 0-4 scale. Photomicrographs (A) indicate increased peribronchiolar infiltrates and altered airway epithelial morphology in RSV-infected mice following prior low- or high-level inhaled DEE exposure. Lung histopathology was further exacerbated in mice exposed to high-level as compared with low-level inhaled DEE. Photomicrograph magnification: x250. (B) Lung histopathology is scored as the mean ± SE of pooled scores within each exposure group (n = 8 animals per group). *Denotes statistical significance at P <= 0.05 as compared with data from air-treated, RSV-infected animals. Arrows indicate altered airway epithelial appearance in the lungs of DEE-exposed mice at 4 d following RSV infection.

 
DEE-induced Inflammatory Mediators during RSV Pathogenesis
The proinflammatory cytokines TNF-{alpha} and IFN-{gamma} are important regulators of lung pathogenesis and antiviral immune mechanisms to respiratory viral infection. ELISA analysis of lung homogenates from air- or DEE-exposed, RSV-infected mice indicated that RSV infection of air-treated animals did not induce TNF-{alpha} or IFN-{gamma} protein expression at 4 d after infection (Figures 3A and 3B). In contrast, both TNF-{alpha} and IFN-{gamma} protein levels were markedly increased in the lungs of infected mice following either low- or high-level DEE exposure. Increased TNF-{alpha} following infection was elevated to similar levels in the lungs of low-level DEE-exposed animals as compared with infected animals exposed to high-level DEE. Induction of IFN-{gamma} during RSV infection by prior exposure to inhaled DEE exhibited a more dose-related increase in IFN-{gamma} levels in the lung, with IFN-{gamma} levels in high-level DEE-exposed, infected animals greater than those exposed to low-level DEE. Lung total protein content, as assessed by Bradford assay, in RSV-infected animals was not elevated by prior exposure to DEE as compared with air-exposed animals (data not shown).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 3. TNF-{alpha} (A) and IFN-{gamma} (B) levels 4 d following RSV infection are increased by prior exposure to inhaled DEE. Proinflammatory cytokine levels were assessed in lung homogenates by ELISA. Data shown represent mean levels (ng/ml) ± SE of n = 8 animals per group from two independent experiments. N.D. indicates protein levels not detectable in the sample preparation. *Denotes statistical significance at P <= 0.05 as compared with data from air-treated, RSV-infected animals. **Denotes statistical significance at P <= 0.05 as compared with data from low-level DEE, RSV-infected animals.

 
Mucous Cell Metaplasia during RSV Infection
Induction of airway epithelial mucus production at 4 d after infection was assessed by Periodic Acid Schiff and Alcian Blue staining in the lungs of mice following air or DEE exposure and subsequent RSV infection. DEE exposure did not alter mucus staining in the lungs of uninfected animals (data not shown). In contrast, mucus staining was apparent in the airways following air treatment and subsequent RSV infection (Figure 4), with intermittent regions of mucus-producing cells observed by light microscopy in larger airways (airway generations 1–3). Mucous production in the airways of infected animals exposed to low-level DEE was more apparent, with increased numbers of cells staining in larger airways and increased mucosubstances in airway epithelial cells. Mucous staining was further increased in the airways of RSV-infected mice exposed to high-level DEE, with markedly apparent staining throughout the airway epithelium and increased size of mucosubstances within the epithelial lining. MCM in the lungs of DEE-exposed, RSV-infected animals was further assessed by quantification of the volume of mucosubstances in the proximal airways (Table 4). Analysis of airway mucosubstances indicated a dose-related increase in MCM in the lungs of DEE-exposed mice following RSV infection. Mucous staining of airway epithelial cells in more distal airways was also occasionally observed in the airways following high-level DEE exposure and RSV infection, suggesting that high-level DEE exposure induced MCM to RSV infection to more distal regions of the tracheobronchial tract.



View larger version (143K):
[in this window]
[in a new window]
 
Figure 4. MCM staining 4 d following RSV infection is increased by prior exposure to inhaled DEE. Photomicrographs of Periodic Acid Schiff and Alcian Blue–stained lung sections indicate increased mucous cell numbers in the airways of RSV-infected animals following exposure to air (a) or either low-level (b) or high-level (c) DEE. Mucous cell staining was observed in more distal airways (d) following in the airways of RSV-infected mice after exposure to high-level DEE. Magnification: x275. Representative micrographs from two independent experiments (n = 8 animals per group) are shown. Quantification of mucous staining is shown in Table 4.

 

View this table:
[in this window]
[in a new window]
 
TABLE 4 Quantitative analysis of MCM histologic staining during RSV infection following prior exposure to inhaled DEE

 
Attenuation of CCSP Production in the Airway Epithelium
To assess other airway epithelial functions that may be further exacerbated during RSV infection by prior exposure to inhaled DEE, CCSP (also called CC-10 or CC-16), an abundant immunomodulatory protein produced by nonciliated airway epithelial (Clara) cells, was assessed by immunohistochemical staining of lung sections (Figure 5A), and CCSP staining quantified by photomicrograph imaging (Table 5). By image analysis, CCSP staining was more intense in the small as compared with larger airways. DEE exposure alone did not alter CCSP staining in larger airways in any groups; however, a mild decrease in CCSP staining in the terminal airways of high-level, but not low-level, DEE-exposed animals was detected by image analysis. Following air exposure and subsequent RSV infection, CCSP was readily apparent in both proximal and distal airways of the lung at 4 d after infection. Clara cell morphology exhibited the normal cuboidal appearance, with a uniform monolayer appearance of the airway epithelium. Following exposure to low-level DEE and subsequent RSV infection, the numbers of CCSP-producing cells, thus Clara cells, were diminished throughout the airways. In addition, qualitative assessment of the intensity of CCSP staining within Clara cells following low-level DEE exposure and RSV infection suggested decreased production of CCSP by Clara cells of the airway epithelium. Following exposure to high-level DEE and RSV infection, CCSP staining was further decreased as compared with exposure to low-level DEE before infection. As observed under higher magnification by light microscopy, the airway epithelium, in particular Clara cells, exhibited an altered morphology, with diminished cytoplasmic projections into the airway lumen and regions of disorganized airway epithelial monolayers (Figure 5A, panel i). Quantitative assessment of CCSP in the lungs of DEE-exposed mice at 4 d after RSV infection indicated a marked decrease in both large and distal airways by prior exposure to low-level DEE (Table 5). CCSP staining was further decreased in both large and small airways of infected mice following high-level DEE as compared with the low-level DEE exposed animals.



View larger version (71K):
[in this window]
[in a new window]
 
Figure 5. CCSP protein levels are diminished in the airways of mice at 4 d following RSV infection by prior exposure to inhaled DEE. (A) CCSP protein was analyzed by immunohistochemistry in lung sections from (a) air-exposed (b) low-level DEE-exposed, and (c) high-level DEE-exposed (d) air exposed, RSV-infected (e) low DEE, RSV-infected, and (f) high-level DEE, RSV-infected animals. Higher magnification images of air-exposed, low DEE-exposed, or high DEE-exposed, RSV-infected animals are shown in micrograph panels g, h, and i, respectively. Immunohistochemistry indicates that prior exposure to DEE decreased CCSP levels in the airways of RSV-infected mice. Magnification: a–f, x180; g–i, ~ x400. (B) Immunoblot analysis of CCSP protein levels in lung homogenates from air-exposed, low-level DEE-exposed, or high-level DEE-exposed animals 4 d after RSV infection. M indicates protein marker lanes, and C indicates untreated, uninfected lung homogenate samples showing CCSP protein abundance under normal conditions. Data represent n = 8 animals per group from two independent experiments. Densitometric analysis of CCSP levels by immunoblot assay is represented in Table 5.

 

View this table:
[in this window]
[in a new window]
 
TABLE 5 Quantitative analysis of CCSP immunohistochemical staining in the lungs of RSV-infected mice following inhaled DEE exposure

 
As a further quantitative measure of CCSP levels in the airway epithelium, lung homogenates from low- or high-level DEE exposure and subsequent RSV infection were analyzed by Western Blot (Figure 5B). CCSP levels were not altered by RSV infection alone as compared with vehicle-instilled, air-exposed samples. Prior exposure to low-level DEE caused a discernible decrease in CCSP levels in the lung following RSV infection. CCSP levels were further decreased by RSV infection in lung homogenates following high-level DEE exposure. DEE exposure or infection status did not change total lung protein content. Densitometric analysis of CCSP protein levels, as measured by immunoblot assay, is shown in Table 6. Similar to findings shown in Figure 5B, CCSP levels were decreased in the lungs of DEE-exposed mice at 4 d after RSV infection. CCSP levels were not changed by exposure to DEE before RSV infection (Table 6).


View this table:
[in this window]
[in a new window]
 
TABLE 6 Densitometric analysis of CCSP protein levels by immunoblot analysis

 
Surfactant Protein Dysregulation following DEE Exposure and RSV Infection
Surfactant protein B is a critical regulator of alveolar surfactant homeostasis and function (20). To assess putative alterations in alveolar function during RSV infection by prior exposure to inhaled DEE, surfactant proprotein B (proSP-B) levels were assessed by immunohistochemical analysis (Figure 6). ProSP-B staining was not altered by DEE exposure alone in either distal airways or alveolar type II cells (Figure 6A). Following RSV infection alone, proSP-B staining was observed by light microscopy specifically in type II cells of the alveoli and alveolar ducts (Figure 6B, panel a), with no discernible decrease when compared with that of uninfected animals. Staining in the airway epithelium, particularly in Clara cells, in the more distal regions of the airways was also detected. Following exposure to low-level DEE, RSV infection caused a moderate decrease in proSP-B staining in alveolar regions of the lung, with increased staining in resident inflammatory cells. Following exposure to high-level DEE, proSP-B staining in alveolar regions was further diminished as compared with prior exposure to low-level DEE. As described previously, proSP-B staining was associated with inflammatory cells in alveolar regions of the lung following RSV infection. Furthermore, proSP-B staining in the airway epithelium following exposure to high-level DEE and subsequent RSV infection was diminished as compared with RSV infection alone or low-level DEE exposure and RSV infection.



View larger version (62K):
[in this window]
[in a new window]
 
Figure 6. ProSP-B staining in the lungs of RSV-infected mice following DEE exposure at 4 d after infection. (A) Immunohistochemical staining of proSP-B in the alveolar (a–c) and airways (d–f) regions of air exposed (a and d), low-level DEE-exposed (b and e), or high-level DEE-exposed (c and f) mice before RSV infection is shown as dark brown staining. ProSP-B staining was not diminished by either low- or high-level DEE exposure. (B) Staining of proSP-B in the alveolar (a–c) and airways (d–f) regions of air-exposed (a and d), low-level DEE-exposed (b and e), or high-level DEE-exposed (c and f) mice at 4 d after RSV infection. ProSP-B staining is decreased in both alveolar type II cells of the alveolar region, as well as in Clara cells of the airway epithelium, at 4 d after RSV infection in mice exposed to either low or high DEE before infection. Arrowheads (a–c) indicate proSP-B staining in alveolar type II cells in pulmonary alveoli; arrows (d–f) indicate staining of proSP-B in Clara cells of the airway epithelium. Micrographs represent data from n = 8 animals from two independent experiments. Magnification: a–c, x450; d–f, x300.

 
Decreased SP-A during RSV Infection following DEE Exposure
SP-A is a member of the collectin family of host defense proteins and an important opsonin for bacteria and viruses infecting the lung. To assess the effect of prior inhaled exposure of DEE on SP-A levels at 4 d following RSV infection, immunohistochemical analysis of SP-A was performed and analyzed under light microscopy (Figures 7A and 7B). SP-A staining in either distal airways or alveolar type II cells was not altered by DEE exposure alone (Figure 7A). SP-A staining in alveolar type II cells and airway epithelium was readily detectable in the lungs of untreated and RSV-infected, air-treated mice, with no discernible changes in SP-A levels. In comparison, prior exposure to high- and low-level DEE decreased SP-A staining in alveolar type II cells and airway epithelial cells during RSV infection (Figure 7B). Differences in SP-A staining were not apparent between the DEE exposure levels. Changes in SP-A staining in the airway epithelium were concordant with the altered airway epithelial cell morphology to pseudostratified and/or columnar cell shape. Changes in alveolar type II cell morphology were not apparent in association with decreased SP-A staining.



View larger version (62K):
[in this window]
[in a new window]
 
Figure 7. SP-A staining in the lungs of RSV-infected mice following DEE exposure at 4 d after infection. (A) Immunohistochemical staining of SP-A in the alveolar (a–c) and airways (d–f) regions of air-exposed (a and d), low-level DEE-exposed (b and e), or high-level DEE-exposed (c and f) mice before RSV infection is shown as dark brown staining. SP-A staining was not diminished by either low- or high-level DEE exposure. (B) Staining of SP-A in the alveolar (a–c) and airways (d–f) regions of air-exposed (a and d), low-level DEE-exposed (b and e), or high-level DEE-exposed (c and f) mice at 4 d after RSV infection. SP-A staining is decreased in both alveolar type II cells of the alveolar region, as well as in Clara cells of the airway epithelium, at 4 d after RSV infection in mice exposured to either low- or high-level DEE before infection. Arrowheads (a–c) indicate SP-A staining in alveolar type II cells in pulmonary alveoli; arrows (d–f) indicate staining of SP-A in Clara cells of the airway epithelium. Micrographs represent data from n = 8 animals from two independent experiments. Magnification: a–c, x450; d–f, x300.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The impact of ambient air pollution on acute respiratory disease has not been fully elucidated. Given the extent to which engine emissions contribute to poor air quality, particularly in urban settings, this study examined the role of inhaled DEE in the altered susceptibility to subsequent respiratory viral infection. The levels of inhaled DEE used in the current study represent plausible human exposure concentrations found in ambient settings (5, 21). Furthermore, the current study examined the impact of air pollutants on susceptibility to RSV, a common viral pathogen that infects nearly every child in infancy and early childhood (3). Herein, prior exposure to inhaled DEE increased RSV gene expression in the lungs of mice. Increased lung inflammation and morphologic changes in the airways were concordant with increased viral transcriptional activity. Markers of airway epithelial function indicated increased mucus response to infection and decreased levels of immunomodulatory proteins, such as expression of CCSP and SP-A. Furthermore, increased lung injury and diminished host defense mechanisms to infection were exacerbated by prior exposure to DEE. These findings are consistent with our hypothesis that inhaled DEE exposure increases the susceptibility to lung disease in response to respiratory viral infection in vivo.

Recently published results have shown that C57Bl/6 strain mice are relatively resistant to RSV infection, having markedly diminished lung viral titers as compared with other, more susceptible strains such as AKR or 129/J strain mice (22). Peak RSV titers in the lungs of multiple strains of mice typically occur at Day 4 after infection, as well as in other experimental animal species, with greatly reduced lung viral titers found at Days 2 and 6 after inoculation (13, 23, 24). Mice were used in the current study because of the ease in performing exposure studies in a small rodent model. Although the study of human RSV in an unnatural host may have limitations, mouse studies of human RSV infection have been useful for delineating immune mechanisms of pathogenesis to RSV vaccines (25). The use of natural rodent paramyxoviruses, such as Sendai virus, may yield new information regarding altered host responses during respiratory viral infection by DEE exposure. Furthermore, the use of more susceptible mouse strains to RSV, such as AKR or 129J strains, may yield information regarding changes in adaptive immune responses to RSV following DEE exposure.

In the current study, viral gene expression was detectable in the lungs of air-exposed C57Bl/6 mice following infection, albeit at low levels. Following exposure to inhaled DEE, RSV gene expression was increased in the lungs of C57Bl/6 mice at Day 4 after infection. The RSV genes F and G were both readily detectable in the lungs of DEE-exposed mice, suggesting that increased viral gene expression was not limited to a particular viral gene subset, but likely reflects an increase in viral replication and/or persistence. Viral gene expression was used in the current study as an indirect assessment of viral lung burden, and has the advantage of allowing repeated analysis when compared with traditional plaque titer assays, which, in the case of RSV, are severely attenuated by repeated freezing and thawing of samples. Both low (30 µg/m3 PM) and high (1,000 µg/m3 PM) DEE exposure levels increased lung viral gene expression at 4 d after infection, with no apparent difference between inhaled DEE exposure levels. The increase in lung viral gene expression during infection by prior exposure to inhaled DEE may result from increased persistence of the initial viral inoculate or diminished antiviral innate mechanisms of viral clearance in the lung. The host molecular determinants that regulate RSV infection and replication have not been fully elucidated at the molecular level in in vivo settings.

Lung inflammation and proinflammatory mediators were increased in the lung following RSV infection by prior exposure to inhaled DEE. The increase in lung inflammation coincided with the increase in lung RSV gene expression following inhaled DEE exposure. Previous studies have shown an association with increased viral persistence and increased lung inflammation in mice rendered more susceptible to respiratory infection. In SP-A-/- gene-targeted mice, lung inflammation is increased concordant with decreased clearance of RSV (4), as well as adenovirus and influenza A infection of the respiratory tract (26, 27). Not surprisingly, proinflammatory mediators such as TNF-{alpha} are likewise increased (4, 26, 27). In the present study, prior exposure to DEE markedly increased TNF-{alpha} and IFN-{gamma} cytokine levels during RSV infection, concurrent with increased lung inflammation and viral gene expression. Importantly, TNF-{alpha} and IFN-{gamma} levels were not detected at 4 d after infection in air-treated, RSV-infected mice, as shown in other studies (2830). As stated previously, C57Bl/6 are relatively resistant to RSV infection (22) and show attenuated host responses to infection, including IFN-{gamma} production (31). Little is known regarding how increased viral persistence may modulate inflammatory and immune responses in the lung; however, mediators of TH1 immune responses are increased in the lungs of SP-A–deficient mice following influenza A infection of the respiratory tract (27).

RSV-related disease in the respiratory tract primarily involves aberrant airway epithelial responses. In addition, the deposition of inhaled particles, such as those found in inhaled engine emissions, likely occurs in the airway epithelium. Following exposure to inhaled DEE, airway-associated lung inflammation to RSV was increased in a manner dependent upon the level of DEE exposure. Furthermore, airway epithelial cell morphology was distinctly altered in the lungs of DEE-exposed, RSV-infected mice, involving proximal and distal airways. Concordant with altered airway epithelial cell changes was the induction of extensive MCM to RSV by prior DEE exposure. In the case of high-level DEE exposure, MCM was observed in more distal airway regions of the lung. Undoubtedly, lung inflammation and inflammatory mediators contributed to the induction of MCM in the airways. It is unclear how persistent viral gene expression in the current setting may contribute to airway epithelial remodeling and mucus responses to RSV exacerbated by inhaled DEE.

Nonciliated bronchiolar epithelial cells, otherwise known as Clara cells, comprise the largest percentage of the distal airway epithelial cell population (32). Although their function is not well understood, Clara cells secrete proteins into the lumen of the airways that may have important host-defense or immunomodulatory functions. CCSP is an abundant, 10- to 16-kD protein secreted by Clara cells with important immunoregulatory functions (33). Our previous studies have shown that CCSP deficiency in gene-targeted mice produces increased inflammatory responses to respiratory infections, including RSV (18, 3436). Likewise, Clara cells produce other molecules important in host defense, including SP-A (33). In the current study, DEE exposure reduced CCSP and SP-A in the airway epithelium following RSV infection, whereas infection alone had little or no effect. Importantly, a mild decrease in CCSP abundance in distal airways was detected in mice exposed to high-level DEE before RSV infection, whereas SP-A staining did not appear to be affected. As stated previously, SP-A deficiency can render the lung more susceptible to respiratory viruses (4, 26, 27). The importance of decreased CCSP and SP-A, collectively as well as independently, in the current experimental setting will require further study and may reflect altered airway epithelial cell function to RSV. Indeed, TNF-{alpha}, which was found markedly elevated in the current study, is known to decrease CCSP promoter function in vivo (37). Thus, the current findings may indicate transcriptional regulation of CCSP, as well as other targets of TNF-{alpha} signaling. Other secreted airway epithelial proteins with host defense or immunomodulatory functions may also be altered by prior DEE exposure and may, in part, play a role in the altered pathogenesis to RSV by exposure to DEE.

In the current study, alveolar surfactant protein responses were altered during RSV infection by prior exposure to inhaled DEE. Both proSP-B and SP-A were diminished in alveolar type II cells, whose primary function is the production and regulation of surfactant homeostasis in the pulmonary alveoli. Furthermore, the appearance of proSP-B and SP-A staining in alveolar phagocytes and inflammatory cells suggests aberrant regulation of type II cell secretion and/or production of surfactant. Similar features of altered surfactant protein regulation have been observed in other inflammatory settings in alveoli (19, 38).

The induction of TNF-{alpha} during RSV infection by prior exposure to DEE may be central to increased host responses and pathogenesis reported herein. TNF-{alpha} regulates SP-B and SP-C gene expression in vitro and in vivo (39, 40). Furthermore, TNF-{alpha} signaling through alveolar type II cells is important in regulating alveolar inflammation and surfactant protein homeostasis in vivo to both viruses and LPS (19, 41). In our recent studies, TNF-{alpha} decreased CCSP promoter activity in airway epithelial cells in vitro, and was associated with diminished CCSP promoter activity in a transgenic mouse model following bacterial infection (37). Further studies will be necessary to delineate the importance of TNF-{alpha} in the increased pathogenesis to RSV by prior DEE exposure.

The exposure concentrations used in this study represent a range of plausible human exposures in occupational and environmental settings to diesel DEE. The high-level DEE is consistent with published exposure concentrations in occupations such as miners and forklift operators (42). The low-level DEE exposure used herein is in the range of an occupational exposure or a high-end environmental exposure in circumstances such as driving on busy freeways or standing on street corners near bus stops impacted by idling buses (42). Although the exposures used in the current study are based on human exposure levels, the extrapolation of human levels to rodents is difficult to determine. The composition of the exposures generated for the current studies was consistent with that of diluted DEE generated in laboratory settings (43).

Previous investigations have assessed the host response and antimicrobial defenses against PM and filter-captured engine emission componenets, having shown that bolus instillation of these components can attenuate bacterial clearance by lung alveolar macrophages (811, 44) and altered responses to allergens (45, 46). With respect to viral infections, exposure to DEE can exacerbate the host response to infection and diminish clearance of influenza virus (47, 48). In addition, exposure to ambient air particles may induce lung injury and inflammation per se (5). The results shown herein indicate that a mild but discernible induction of lung inflammation was detectable with inhaled DEE exposure before RSV infection. In contrast to previously reported studies, however, the proinflammatory cytokines TNF-{alpha} and IFN-{gamma} were not detectable in the lungs of mice following DEE exposure alone. These differences may be the result of using whole (particles and gaseous phase) diluted DEE aerosols at relatively low experimental concentrations, as compared with the more common use of instilled DEE particles as a bolus administration (10, 12, 49). Species differences (i.e., mouse versus rat, etc.) may also account for differences in the effects of DEE exposure presented in the current study (10). Likewise, the exposure period used herein, 1 wk at 6 h/d, is substantially shorter than other studies reported (47, 50). The importance of prior lung injury and inflammation on subsequent host responses to respiratory infection is not apparent from these studies. Further studies are also needed to clarify the dose- and temporal-related effects of inhaled DEE on lung function and homeostasis.

In the present studies, prior exposure to inhaled DEE exacerbated the lung inflammation and injury to subsequent RSV infection, rendering a relatively resistant mouse strain more susceptible to RSV-induced lung disease. RSV gene expression was increased in the lungs following DEE exposure, concurrent with increased lung inflammation and altered airway epithelial cell remodeling. Airway and alveolar epithelial markers indicate that both lung compartments were affected by DEE exposure, including mucous cell responses and surfactant protein homeostasis during RSV infection. These studies present novel findings regarding the impact of DEE on pulmonary responses to a common viral pathogen. Furthermore, the findings herein may provide insight into the pulmonary epithelial determinants that regulate the host response to RSV infection and exposure to ambient air pollutants.


    Acknowledgments
 
The authors wish to thank the National Environmental Respiratory Center (NERC) for operation of the diesel engine exposure systems. Richard K. White constructed the exposure system under the supervision of Edward B. Barr. Jose Madrid, Nick Sylvas, and Terry Zimmerman operated the system. This work was performed in conjunction with the NERC, at the Lovelace Respiratory Research Institute, with funds from multiple government and industry sponsors, including the US EPA. This article is not intended to represent the views or policies of any NERC sponsor. This work was also funded in part by a Pilot Project Award from the NIEHS Development Center Grant (P20-ES09781-04) (K.S.H.); the Health Effects Institute, an organization jointly funded by the US EPA, and automotive manufacturers (K.S.H); and the National Institutes of Health grant HL-66964 (K.S.H.). Lovelace Respiratory Research Institute is fully accredited by the Association for the Assessment and Accreditation of Laboratory Animal Care International.

Received in original form July 2, 2002

Received in final form October 2, 2002


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Shay, D. K., R. C. Holman, R. D. Newman, L. L. Liu, J. W. Stout, and L. J. Anderson. 1999. Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA 282:1440–1446.[Abstract/Free Full Text]
  2. Sigurs, N. 2001. Epidemiologic and clinical evidence of a respiratory syncytial virus–reactive airway disease link. Am. J. Respir. Crit. Care Med. 163:S2–S6.[Free Full Text]
  3. Collins, P. L., R. M. Chanock, and B. R. Murphy. 2001. Respiratory syncytial virus. In Virology, 4th ed. D. Knipe, editor. Raven Press, New York, NY. 1443–1485.
  4. LeVine, A. M., J. Gwozdz, J. Stark, M. Bruno, J. Whitsett, and T. Korfhagen. 1999. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J. Clin. Invest. 103:1015–1021.[Medline]
  5. Cohen, A. J., and K. J. Nikula. 1999. The health effects of diesel exhaust: laboratory and epidemiology studies. In Air Pollution and Health. S. T. Holgate, J. M. Samet., H. S. Koren, and R. L. Maynard, editors. Academic Press, San Diego. 707–745.
  6. Dockery, D. W., F. E. Speizer, D. O. Stram, J. H. Ware, J. D. Spengler, and B. G. Ferris, Jr. 1989. Effects of inhalable particles on respiratory health of children. Am. Rev. Respir. Dis. 139:587–594.[Medline]
  7. Ware, J. H., B. G. Ferris, Jr., D. W. Dockery, J. D. Spengler, D. O. Stram, and F. E. Speizer. 1986. Effects of ambient sulfur oxides and suspended particles on respiratory health of preadolescent children. Am. Rev. Respir. Dis. 133:834–842.[Medline]
  8. Jakab, G. J. 1993. The toxicologic interactions resulting from inhalation of carbon black and acrolein on pulmonary antibacterial and antiviral defenses. Toxicol. Appl. Pharmacol. 121:167–175.[CrossRef][Medline]
  9. Zelikoff, J. T., E. Parsons, and R. B. Schlesinger. 1993. Inhalation of particulate lead oxide disrupts pulmonary macrophage-mediated functions important for host defense and tumor surveillance in the lung. Environ. Res. 62:207–222.[Medline]
  10. Castranova, V., J. Y. Ma, H. M. Yang, J. M. Antonini, L. Butterworth, M. W. Barger, J. Roberts, and J. K. Ma. 2001. Effect of exposure to diesel exhaust particles on the susceptibility of the lung to infection. Environ. Health Perspect. 109:609–612.
  11. Yang, H. M., M. W. Barger, V. Castranova, J. K. Ma, J. J. Yang, and J. Y. Ma. 1999. Effects of diesel exhaust particles (DEP), carbon black, and silica on macrophage responses to lipopolysaccharide: evidence of DEP suppression of macrophage activity. J. Toxicol. Environ. Health A 58:261–278.[CrossRef][Medline]
  12. Yang, H. M., J. M. Antonini, M. W. Barger, L. Butterworth, B. R. Roberts, J. K. Ma, V. Castranova, and J. Y. Ma. 2001. Diesel exhaust particles suppress macrophage function and slow the pulmonary clearance of Listeria monocytogenes in rats. Environ. Health Perspect. 109:515–521.[Medline]
  13. Graham, B. S., M. D. Perkins, P. F. Wright, and D. T. Karzon. 1988. Primary respiratory syncytial virus infection in mice. J. Med. Virol. 26:153–162.[Medline]
  14. Buckingham, K. W., and W. E. Wyder. 1981. Rapid tracheal infusion method for routine lung fixation using rat and guinea pig. Toxicol. Pathol. 9:17–20.
  15. Wang, S. Z., C. L. Rosenberger, T. M. Espindola, E. G. Barrett, Y. Tesfaigzi, D. E. Bice, and K. S. Harrod. 2001. CCSP modulates airway dysfunction and host responses in an Ova-challenged mouse model. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:L1303–L1311.[Abstract/Free Full Text]
  16. Shi, Z. O., M. J. Fischer, G. T. De Sanctis, M. R. Schuyler, and Y. Tesfaigzi. 2002. IFN-gamma, but not Fas, mediates reduction of allergen-induced mucous cell metaplasia by inducing apoptosis. J. Immunol. 168:4764–4771.[Abstract/Free Full Text]
  17. Harkema, J. R., and J. A. Hotchkiss. 1992. In vivo effects of endotoxin on intraepithelial mucosubstances in rat pulmonary airways: quantitative histochemistry. Am. J. Pathol. 141:307–317.[Abstract]
  18. Hayashida, S., K. S. Harrod, and J. A. Whitsett. 2000. Regulation and function of CCSP during pulmonary Pseudomonas aeruginosa infection in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 279:L452–L459.[Abstract/Free Full Text]
  19. Harrod, K. S., A. D. Mounday, and J. A. Whitsett. 2000. Adenoviral E3–14.7K protein in LPS-induced lung inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 278:L631–L639.[Abstract/Free Full Text]
  20. Whitsett, J. A., L. M. Nogee, T. E. Weaver, and A. D. Horowitz. 1995. Human surfactant protein B: structure, function, regulation, and genetic disease. Physiol. Rev. 75:749–757.[Abstract/Free Full Text]
  21. Choudhury, A. H., M. E. Gordian, and S. S. Morris. 1997. Associations between respiratory illness and PM10 air pollution. Arch. Environ. Health 52:113–117.[Medline]
  22. Stark, J. M., S. A. McDowell, V. Koenigsknecht, D. R. Prows, J. E. Leikauf, A. M. Le Vine, and G. D. Leikauf. 2002. Genetic susceptibility to respiratory syncytial virus infection in inbred mice. J. Med. Virol. 67:92–100.[CrossRef][Medline]
  23. Richardson, L. S., R. B. Belshe, D. L. Sly, W. T. London, D. A. Prevar, E. Camargo, and R. M. Chanock. 1978. Experimental respiratory syncytial virus pneumonia in cebus monkeys. J. Med. Virol. 2:45–59.[Medline]
  24. Prince, G. A., S. C. Suffin, D. A. Prevar, E. Camargo, D. L. Sly, W. T. London, and R. M. Chanock. 1979. Respiratory syncytial virus infection in owl monkeys: viral shedding, immunological response, and associated illness caused by wild-type virus and two temperature-sensitive mutants. Infect. Immun. 26:1009–1013.[Abstract/Free Full Text]
  25. Graham, B. S., J. A. Rutigliano, and T. R. Johnson. 2002. Respiratory syncytial virus immunobiology and pathogenesis. Virology 297:1–7.[CrossRef][Medline]
  26. Harrod, K. S., B. C. Trapnell, K. Otake, T. R. Korfhagen, and J. A. Whitsett. 1999. SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection. Am. J. Physiol. 277:L580–L588.
  27. LeVine, A. M., K. Hartshorn, J. Elliott, J. Whitsett, and T. Korfhagen. 2002. Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection. Am. J. Physiol. Lung Cell. Mol. Physiol. 282:L563–L572.[Abstract/Free Full Text]
  28. Anderson, L. J., C. Tsou, C. Potter, H. L. Keyserling, T. F. Smith, G. Ananaba, and C. R. Bangham. 1994. Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells. J. Infect. Dis. 170:1201–1208.[Medline]
  29. Durbin, J. E., T. R. Johnson, R. K. Durbin, S. E. Mertz, R. A. Morotti, R. S. Peebles, and B. S. Graham. 2002. The role of IFN in respiratory syncytial virus pathogenesis. J. Immunol. 168:2944–2952.[Abstract/Free Full Text]
  30. van Schaik, S. M., N. Obot, G. Enhorning, K. Hintz, K. Gross, G. E. Hancock, A. M. Stack, and R. C. Welliver. 2000. Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice. J. Med. Virol. 62:257–266.[CrossRef][Medline]
  31. Johnson, T. R., S. Hong, L. Van Kaer, Y. Koezuka, and B. S. Graham. 2002. NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus. J. Virol. 76:4294–4303.[Abstract/Free Full Text]
  32. Harkema, J. R., A. Mariassy, J. St. George, D. M. Hyde, and C. G. Plopper. 1991. The airway epithelium: physiology, pathophysiology, and pharmacology. In Lung Biology in Health and Disease. S. G. Farmer and D. W. P. Hay, editors. Lung Biology Marcel Dekker, New York.
  33. Singh, G., and S. L. Katyal. 1997. Clara cells and Clara cell 10 kD protein (CC10). Am. J. Respir. Cell Mol. Biol. 17:141–143.[Free Full Text]
  34. Harrod, K. S., A. D. Mounday, B. R. Stripp, and J. A. Whitsett. 1998. Clara cell secretory protein decreases lung inflammation after acute virus infection. Am. J. Physiol. 275:L924–L930.
  35. Ikegami, M., K. S. Harrod, J. A. Whitsett, and A. H. Jobe. 1999. CCSP deficiency does not alter surfactant homeostasis during adenoviral infection. Am. J. Physiol. 277:L983–L987.[Abstract/Free Full Text]
  36. Wang, S. Z., C. L. Rosenberger, J. M. Stark, B. S. Graham, and K. S. Harrod. 2002. Clara cell secretory protein modulates lung inflammation and airway reactivity in respiratory syncytial virus infection. Am. J. Respir. Crit. Care Med. 165:A459. (Abstr.)
  37. Harrod, K. S., and R. J. Jaramillo. 2002. Pseudomonas aeruginosa and tumor necrosis factor-{alpha} attenuate Clara cell secretory protein promoter function. Am. J. Respir. Cell Mol. Biol. 26:216–223.[Abstract/Free Full Text]
  38. Zsengeller, Z. K., S. E. Wert, C. J. Bachurski, K. L. Kirwan, B. C. Trapnell, and J. A. Whitsett. 1997. Recombinant adenoviral vector disrupts surfactant homeostasis in mouse lung. Hum. Gene Ther. 8:1331–1344.[Medline]
  39. Bachurski, C. J., G. S. Pryhuber, S. W. Glasser, S. E. Kelly, and J. A. Whitsett. 1995. Tumor necrosis factor-alpha inhibits surfactant protein C gene transcription. J. Biol. Chem. 270:19402–19407.[Abstract/Free Full Text]
  40. Pryhuber, G. S., C. Bachurski, R. Hirsch, A. Bacon, and J. A. Whitsett. 1996. Tumor necrosis factor-alpha decreases surfactant protein B mRNA in murine lung. Am. J. Physiol. 270:L714–L721.[Abstract/Free Full Text]
  41. Harrod, K. S., T. W. Hermiston, B. C. Trapnell, W. S. Wold, and J. A. Whitsett. 1998. Lung-specific expression of adenovirus E3–14.7K in transgenic mice attenuates adenoviral vector-mediated lung inflammation and enhances transgene expression. Hum. Gene Ther. 9:1885–1898.[Medline]
  42. Lloyd, A. C., and T. A. Cackette. 2001. Diesel engines: environmental impact and control. J. Air Waste Manag. Assoc. 51:809–847.[Medline]
  43. Kittelson, D. B. 1998. Engines and nanoparticles: a review. J. Aerosol Sci. 29:575–588.[CrossRef]
  44. Castranova, V., L. Bowman, M. J. Reasor, T. Lewis, J. Tucker, and P. R. Miles. 1985. The response of rat alveolar macrophages to chronic inhalation of coal dust and/or diesel exhaust. Environ. Res. 36:405–419.[Medline]
  45. Fahy, O., S. Senechal, J. Pene, A. Scherpereel, P. Lassalle, A. B. Tonnel, H. Yssel, B. Wallaert, and A. Tsicopoulos. 2002. Diesel exposure favors Th2 cell recruitment by mononuclear cells and alveolar macrophages from allergic patients by differentially regulating macrophage-derived chemokine and IFN-{gamma}–induced protein-10 production. J. Immunol. 168:5912–5919.[Abstract/Free Full Text]
  46. Maejima, K., K. Tamura, T. Nakajima, Y. Taniguchi, S. Saito, and H. Takenaka. 2001. Effects of the inhalation of diesel exhaust, Kanto loam dust, or diesel exhaust without particles on immune responses in mice exposed to Japanese cedar (Cryptomeria japonica) pollen. Inhal. Toxicol. 13:1047–1063.[CrossRef][Medline]
  47. Hahon, N., J. A. Booth, F. Green, and T. R. Lewis. 1985. Influenza virus infection in mice after exposure to coal dust and diesel engine emissions. Environ. Res. 37:44–60.[Medline]
  48. Rabovsky, J., D. J. Judy, D. J. Rodak, and M. Petersen. 1986. Influenza virus-induced alterations of cytochrome P-450 enzyme activities following exposure of mice to coal and diesel particulates. Environ. Res. 40:136–144.[Medline]
  49. Saito, Y., A. Azuma, S. Kudo, H. Takizawa, and I. Sugawara. 2002. Effects of diesel exhaust on murine alveolar macrophages and a macrophage cell line. Exp. Lung Res. 28:201–217.[CrossRef][Medline]
  50. Saito, Y., A. Azuma, S. Kudo, H. Takizawa, and I. Sugawara. 2002. Long-term inhalation of diesel exhaust affects cytokine expression in murine lung tissues: comparison between low- and high-dose diesel exhaust exposure. Exp. Lung Res. 28:493–506.[CrossRef][Medline]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles